MCAG Mountain Crest Acquisition Corp. V
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1859035 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| SG&A expense | $80,542 | $100,890 | $120,046 | $83,561 | $76,525 | $120,471 | $191,225 | $187,317 |
| Operating income | -$80,542 | -$100,890 | -$120,046 | -$83,561 | -$76,525 | -$120,471 | -$191,225 | -$187,317 |
| Interest expense | — | — | — | — | — | — | — | $0 |
| Pretax income | -$72,724 | $6,616 | -$112,654 | -$70,702 | -$64,180 | -$108,279 | -$179,106 | -$147,190 |
| Income tax | $1,368 | $1,438 | $1,321 | $2,028 | $2,299 | $2,295 | $2,272 | $6,266 |
| Net income | $74,092 | $5,178 | -$113,975 | -$72,730 | -$66,479 | -$110,574 | -$181,378 | -$153,456 |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $100,127 | $18,299 | $97,101 | $11,909 | $41,172 | $25,321 | $27,943 | $116,658 |
| Current assets | $101,794 | $34,315 | $138,557 | $32,927 | $78,141 | $88,241 | $42,540 | $156,779 |
| Total assets | $965,149 | $889,852 | $986,588 | $873,566 | $1.27M | $1.27M | $1.21M | $1.31M |
| Current liabilities | $1.93M | $1.78M | $1.88M | $1.65M | $1.84M | $1.77M | $1.60M | $1.52M |
| Total liabilities | $4.00M | $3.85M | $3.95M | $3.72M | $3.91M | $3.84M | $3.67M | $3.59M |
| Shareholders' equity | -$3.88M | -$3.80M | -$3.80M | -$3.68M | -$3.80M | -$3.73M | -$3.62M | -$3.44M |
| Shares outstanding | 2.80M | 2.80M | 2.80M | 2.80M | 2.80M | 2.80M | 2.80M | 2.80M |
| Cash flow statement | ||||||||
| Operating cash flow | -$68,172 | -$78,802 | -$164,808 | -$286,512 | -$134,149 | -$232,622 | -$88,715 | -$309,838 |
| Investing cash flow | — | — | — | — | — | — | — | $4.88M |
| Financing cash flow | $150,000 | $0 | $250,000 | -$105,538 | $150,000 | — | — | -$4.50M |
Free plan shows the latest 8 periods; Pro shows all 22 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.